We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$9.86M
1-Year Est. Return
9.93%
This Fund
S&P 500
This Quarter
Est. Return
+4.05%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$118M
AUM Growth
–
Cap. Flow
+$122M
Cap. Flow
% of AUM
103.01%
Top 10 Holdings %
Top 10 Hldgs %
7.37%
Holding
380
New
380
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booz Allen Hamilton
BAH
|
+$1M |
| 2 |
Verizon
VZ
|
+$937K |
| 3 |
MODV
ModivCare
MODV
|
+$925K |
| 4 |
EXL Service
EXLS
|
+$913K |
| 5 |
Iridium Communications
IRDM
|
+$894K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.09% |
| 2 | Industrials | 15.8% |
| 3 | Technology | 14.93% |
| 4 | Healthcare | 10.46% |
| 5 | Communication Services | 9.46% |
Similar funds
WA
BS
RG
MP
AIA
CCM
DFA
T
PharVision Advisers's Q4 2024 Portfolio in Review
Q4 2024 is the first quarter with a 13F filing on record for PharVision Advisers, which disclosed 380 positions worth $118M. Its ten largest holdings account for 7.4% of the portfolio.
Its largest position is Booz Allen Hamilton: 6,467 shares worth $832K.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, followed by Industrials and Technology.
- PharVision Advisers's largest Q4 2024 buy was Booz Allen Hamilton: 6,467 shares worth $832K.
- PharVision Advisers's ten largest holdings make up 7.4% of its $118M portfolio in Q4 2024.
- PharVision Advisers disclosed 380 positions in Q4 2024, its first 13F filing on record.
Based on PharVision Advisers's 13F filing for Q4 2024, filed 18 Feb 2025.